Weekly buprenorphine injection proves more effective for pregnant women with opioid use disorder
Source ↗
👁 0
💬 0
Substance use disorder is a leading cause of pregnancy-related and pregnancy-associated death in Tennessee.
Vanderbilt Health continues to be on the forefront of addressing the increasing toll of the opioid crisis on pregnant and postpartum women and their infants.
It is among 13 sites in the United States to evaluate the use of sublingual buprenorphine, the evidence-based standard of care, versus an injectable, extended-release formulation of the medication in the treatment of pregnant wo
Vanderbilt Health continues to be on the forefront of addressing the increasing toll of the opioid crisis on pregnant and postpartum women and their infants.
It is among 13 sites in the United States to evaluate the use of sublingual buprenorphine, the evidence-based standard of care, versus an injectable, extended-release formulation of the medication in the treatment of pregnant wo
Comments (0)